Type I IFNs produced by plasmacytoid dendritic cells enhance the cytotoxic activities of natural killer cells and CD8+ CTLs and promote the differentiation of CD4+ helper T cells, resulting in enhanced tumor-specific immune responses. This evidence concerns the gene CD4 and neoplasm.